NCT01979172

Brief Summary

The study aims at determining the best biometry calculation formula to be used in IOL calculation of cataract patients how previously underwent laser refractive correction surgery

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
400

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2013

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2013

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

November 3, 2013

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 8, 2013

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2014

Completed
Last Updated

November 8, 2013

Status Verified

November 1, 2013

Enrollment Period

4 months

First QC Date

November 3, 2013

Last Update Submit

November 3, 2013

Conditions

Keywords

LASIKIntraocular lensBiometryIOL master

Outcome Measures

Primary Outcomes (1)

  • Best Selected IOL calculation formula

    6 weeks

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patient undergoing laser refractive surgery

You may qualify if:

  • all patient undergoing laser refractive surgery

You may not qualify if:

  • previous ophthalmic surgery
  • previous trauma
  • ocular pathology other than refractive error

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Watany Eye Hopsital

Cairo, Cairo Governorate, Egypt

RECRUITING

Related Links

MeSH Terms

Conditions

CataractRefractive Errors

Condition Hierarchy (Ancestors)

Lens DiseasesEye Diseases

Study Officials

  • Rami R Fikry, MD/FRCS

    Watany Eye Hospital

    PRINCIPAL INVESTIGATOR
  • Ahmed Assaf, MD/FRCS

    Watany Eye Hospital

    STUDY DIRECTOR
  • Ahmed Osama, MS

    Watany Eye Hospital

    PRINCIPAL INVESTIGATOR
  • Moahmed O El Bahrawy, MS

    Watany Eye Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

mohamed O El Bahrawy, MS

CONTACT

Study Design

Study Type
observational
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr.

Study Record Dates

First Submitted

November 3, 2013

First Posted

November 8, 2013

Study Start

November 1, 2013

Primary Completion

March 1, 2014

Study Completion

March 1, 2014

Last Updated

November 8, 2013

Record last verified: 2013-11

Locations